Fenwick & West advised TrialSpark on the deal.TrialSpark, a technology-driven pharma company that runs end-to-end clinical trials, announced its $156 million Series C financing. The round was…
TrialSpark’s $156 Million Series C Financing


Fenwick & West advised TrialSpark on the deal.TrialSpark, a technology-driven pharma company that runs end-to-end clinical trials, announced its $156 million Series C financing. The round was…
…